gip glp-1 dual agonist and Triple Gut Peptide Agonists on the Horizon for the Treatment of Type 2 Diabetes and Obesity. An Overview of Preclinical and Clinical Data Effects of tirzepatide, a dual

Description

Advertisement Large retrospective analysis may prompt prospective studies How to talk about lifetime risk, treatment goals, Lp(a) testing, statin skepticism and more Robust signal from observational study raises prospect of a long-sought medical therapy Retrospective analysis finds lower mortality rates, fewer hospital visits among patients with Type 1 diabetes using GLP-1 Therapies Study shows significantly reduced risk of mortality and disease complications in patients receiving GLP-1 agonists Observational evidence of neuroprotection with GLP-1 receptor agonists and SGLT-2 inhibitors Study is first to show reduction in autoimmune disease with the common diabetes and obesity drugs Surgical intervention linked to increased lifespan and reduced complications

Microvascular arterial disease of the brain and the heart: a shared pathogenesis

doi: 10.1016/j.eclinm.2025.103385 [DOI] [PMC free article] [PubMed] [Google Scholar] 139.Sun H, Hao Y, Liu H, et al

food or liquid getting into the lungs during surgery or other procedures that use anesthesia or deep sleepiness (deep sedation)

Over time, these processes gradually become less efficient, leading to the accumulation of biological changes that affect metabolism, tissue function, and resilience across organ systems